These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Influence of the timing of blood transfusion on experimental tumor growth. Francis DM; Clunie GJ J Surg Res; 1993 Mar; 54(3):237-41. PubMed ID: 8474239 [TBL] [Abstract][Full Text] [Related]
7. Allogeneic blood transfusion-induced enhancement of tumor growth: two animal models showing amelioration by leukodepletion and passive transfer using spleen cells. Blajchman MA; Bardossy L; Carmen R; Sastry A; Singal DP Blood; 1993 Apr; 81(7):1880-2. PubMed ID: 8461473 [TBL] [Abstract][Full Text] [Related]
8. [Enhancement by blood transfusions of transplanted tumor growth in mice]. Kagawa S Nihon Geka Gakkai Zasshi; 1984 Jun; 85(6):513-20. PubMed ID: 6333580 [TBL] [Abstract][Full Text] [Related]
9. Leukocyte adherence inhibition (LAI) in rats bearing transplantable syngeneic tumors of different immunogenicity. Tank B; Marquet RL; Vennemans E; Westbroek DL Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1539-46. PubMed ID: 3913605 [TBL] [Abstract][Full Text] [Related]
10. Blood transfusion and surgery: the effect on growth of a syngeneic sarcoma. Parrott NR; Lennard TW; Proud G; Shenton BK; Givan A; White MD; Taylor R Ann R Coll Surg Engl; 1990 Mar; 72(2):77-81. PubMed ID: 2334101 [TBL] [Abstract][Full Text] [Related]
11. Effect of allogeneic blood transfusions on the growth of two different tumours in the rat. Rössler W; Dreikorn K; Lenhard V; Zeller WJ; Scholler P Urol Int; 1985; 40(4):217-9. PubMed ID: 4049579 [TBL] [Abstract][Full Text] [Related]
12. Control of progression of local tumor and pulmonary metastasis of the 3LL Lewis lung carcinoma by different histocompatibility requirements in mice. Isakov N; Feldman M; Segal S J Natl Cancer Inst; 1981 May; 66(5):919-26. PubMed ID: 6939934 [TBL] [Abstract][Full Text] [Related]
13. Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: the importance of the timing of the leukodepletion. Bordin JO; Bardossy L; Blajchman MA Blood; 1994 Jul; 84(1):344-8. PubMed ID: 8018929 [TBL] [Abstract][Full Text] [Related]
14. Allogeneic blood transfusion reduces murine pulmonary natural killer (NK) activity and enhances lung metastasis of a syngeneic tumour. Clarke PJ; Burton RC; Wood KJ Int J Cancer; 1993 Dec; 55(6):996-1002. PubMed ID: 8253537 [TBL] [Abstract][Full Text] [Related]
15. Transfusion-related immunomodulation due to peripheral blood dendritic cells expressing the CD200 tolerance signaling molecule and alloantigen. Clark DA; Gorczynski RM; Blajchman MA Transfusion; 2008 May; 48(5):814-21. PubMed ID: 18298594 [TBL] [Abstract][Full Text] [Related]
17. The influence of blood loss on tumour growth: effect and mechanism in an experimental model. Hoynck van Papendrecht MA; Busch OR; Jeekel J; Marquet RL Neth J Surg; 1991 Aug; 43(4):85-8. PubMed ID: 1944994 [TBL] [Abstract][Full Text] [Related]
18. Acceleration of B16 melanoma growth in mice after blood transfusion. Francis DM; Burren CP; Clunie GJ Surgery; 1987 Sep; 102(3):485-92. PubMed ID: 3629476 [TBL] [Abstract][Full Text] [Related]
19. Semi-allogeneic (F1) versus fully allogeneic blood transfusions: differences in their ability to induce specific immunological unresponsiveness. Roelen DL; Dover EL; Niimi M; Young NT; Morris PJ; Wood KJ Eur J Immunol; 1996 Jul; 26(7):1468-74. PubMed ID: 8766548 [TBL] [Abstract][Full Text] [Related]
20. [Effect of immunomodulation following allogeneic blood transfusion on tumor neogenesis and growth--experimental studies in rats]. Scholler PM; Zeller WJ; Rössler W; Lenhard V; Weber E; Schmähl D; Dreikorn K Arch Geschwulstforsch; 1987; 57(2):81-90. PubMed ID: 3592925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]